-
152
DAFTAR PUSTAKA
Abebe F, Belay M, Legesse M, K.L.M.C F, Ottenhoff THM. 2018. IgA and IgG against
Mycobacterium tuberculosis Rv2031 discriminate between pulmonary
tuberculosis patients, Mycobacterium tuberculosis-infected and non-infected
individuals. Plos One. vol. 13. no. 1. pp. e0190989.
Achkar JM, Chan J, Casadevall A. 2015. B cells and antibodies in the defense against
Mycobacterium tuberculosis infection. Immunological Reviews. vol. 264. pp. 167-
181.
Adjemian J, Frankland TB, Daida YG, Honda JR, Olivier KN, Zelazny A, Honda S,
Prevots DR. 2017. Epidemiology of nontuberculous mycobacterial lung disease
and tuberculosis, Hawaii, USA. Emerging Infectious Diseases. vol. 23. no. 3. pp.
439-447.
Ahmad F, Zubair S, Gupta P, Gupta UD, Patel R, Owais M. 2017. Evaluation of
aggregated Ag85B antigen for its biophysical properties, immunogenicity, and
vaccination potential in a murine model of tuberculosis infection. Frontiers in
Immunology. vol. 8. pp. 1608.
Applied Biosystems. 2009. DNA sequencing by capillary electrophoresis applied
biosystems chemistry guide second edition. Applied Biosystems. US. diakses 18
April 2016.
https://www3.appliedbiosystems.com/cms/groups/mcb_support/documents/gener
aldocuments/cms_041003.pdf.
Aston SJ, Ho A, Jary H, Huwa J, Mitchell T, Ibitoye S, Greenwood S, Joekes E, Daire
A, Mallewa J, Everett D, Nyirenda M, Faragher B, Mwandumba HC, Heyderman
RS, Gordon SB. 2019. Aetiology and risk factors for mortality in an adult
community-acquired pneumonia cohort in Malawi. American Journal of
Respiratory and Critical Care Medicine. doi: 10.1164/rccm.201807-1333OC. (In
Press).
Babaki MKZ, Soleimanpour S, Rezaee SA. 2017. Antigen 85 complex as a powerful
Mycobacterium tuberculosis immunogene: Biology, immune-pathogenicity,
applications in diagnosis, and vaccine design. Microbial Pathogenesis. vol. 112.
pp. 20-29.
Beamer GL, Cyktor J, Flaherty DK, Stromberg PC, Bridget C, Turner J. 2012.
Mycobacterium tuberculosis infected CBA/J mice can generate robust and
protective responses to antigen Ag85 when delivered as a soluble protein, but fail
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
DISERTASI PROFIL RESPONS IMUN ... DESAK NYOMAN SURYA SUAMEITRIA DEWI
https://www3.appliedbiosystems.com/cms/groups/mcb_support/documents/generaldocuments/cms_041003.pdfhttps://www3.appliedbiosystems.com/cms/groups/mcb_support/documents/generaldocuments/cms_041003.pdf
-
153
to respond efficiently in the context of natural infection. European Journal of
Immunology. vol. 42. no. 4. pp. 870-879.
Belay M, Legesse M, Mihret A, Ottenhoff THM, Franken KL, Bjune G, Abebe F. 2016.
IFN-g and IgA against non-methylated heparin-binding hemagglutinin as markers
of protective immunity and latent tuberculosis: results of a longitudinal study from
an endemic setting. Journal of Infection. vol. 72. pp. 189-200.
Belisle JT, Vissa VD, Sievert T, Takayama K, Brennan PJ, Besra GS. 1997. Role of
the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science.
vol. 276. pp. 1420-1422.
Berkowitz N, Okorie A, Goliath R, Levitt N, Wilkinson RJ, Oni T. 2018. The
prevalence and determinants of active tuberculosis among diabetes patients in
Cape Town, South Africa, a high HIV/TB burden setting. Diabetes Research and
Clinical Practice. vol. 138. pp. 16-25.
Bhunia SK, Sarkar M, Banerjee A, Giri B. 2015. An update on pathogenesis and
management of tuberculosis with special reference to drug resistant. Asian Pacific
Journal of Tropical Disease. vol. 5. no. 9. pp. 673-686.
Biofeng. 2013. pET-SUMO. Biofeng. China. diakses 4 Mei 2018.
http://www.biofeng.com/zaiti/dachang/pET-SUMO.html
Brown TA. 2010. Gene cloning and DNA analysis an introduction sixth edition. John
Wiley &Sons Ltd. UK.
Brown TA. 2016. Gene cloning and DNA analysis an introduction seventh edition.
John Wiley &Sons Ltd. UK.
Burmester È and Pezzutto A. 2003. Color atlas of immunology. Thieme. New York.
Carroll KC, Hobden JA, Miller S, Morse SA, Mietzner TA, Detrick B, Mitchell TG,
McKerrow JH, Sakanari JA. 2016. Jawetz, melnick & adelberg’s medical
microbiology 27th edition. McGraw-Hill Companies Inc. USA.
Cerqueira-Rodrigues B, Mendes A, Correia-Neves M, Nobrega C. 2018. Ag85-focused
T-cell immune response controls Mycobacterium avium chronic infection. Plos
one. vol. 13. no. 3. pp. e0193596.
Chakraborthy A, Shivananjaiah AJ, Ramaswamy S, Chikkavenkatappa N. 2018. Chest
X ray score (Timika score): an useful adjunct to predict treatment outcome in
tuberculosis. Advances in Respiratory Medicine. vol. 86. no. 5. pp. 205-210.
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
DISERTASI PROFIL RESPONS IMUN ... DESAK NYOMAN SURYA SUAMEITRIA DEWI
-
154
Chen JM, Pojer F, Blasco B, Cole ST. 2010. Towards anti-virulence drugs targeting
esx-1 mediated pathogenesis of Mycobacterium tuberculosis, Drug Discovery
Today: Disease Mechanisms. vol. 7. no. 1. pp. 25-31.
Cheng J, Wang L, Zhang H, Xia Y. 2015. Diagnostic value of symptom screening for
pulmonary tuberculosis in China. Plos One. vol. 10. no. 5. pp. e0127725.
Chien JY, Lai CC, Sheng WH, Yu CJ, Hsueh PR. 2014. Pulmonary infection and
colonization with nontuberculous mycobacteria, Taiwan, 2000–2012. Emerging
Infectious Diseases. vol. 20. no. 8. pp. 1382–1385.
Chingonzoh R, Manesen MR, Madlavu MJ, Sopiseka N, Nokwe M, Emwerem M,
Musekiwa A, Kuonza LR. 2018. Risk factors for mortality among adults registered
on the routine drug resistant tuberculosis reporting database in the Eastern Cape
Province, South Africa, 2011 to 2013. Plos One. vol. 13. no. 8. pp. e0202469.
Chuchottaworn C, Thanachartwet V, Sangsayunh P, Than TZM, Sahassananda D,
Surabotsophon M, Desakorn V. 2015. Risk factors for multidrug-resistant
tuberculosis among patients with pulmonary tuberculosis at the central chest
institute of Thailand. Plos One. vol. 10. no. 10. pp. e0139986.
Coico R and Sunshine G. 2015. Immunology: a short course. John Wiley & Sons. West
Sussex
Collins CH, Lyne PM, Grange JM, Falkinham III JO. 2004. Collins and Lyne’s
microbiological methods eighth edition. Arnold. London.
Coppola M, Arroyo L, van Meijgaarden KE, Franken KLMC, Geluk A, Barrera LF,
Ottenhoff THM. 2017. Differences in IgG responses against infection phase
related Mycobacterium tuberculosis (Mtb) specific antigens in individuals
exposed or not to Mtb correlate with control of TB infection and progression.
Tuberculosis. vol. 106. pp. 25-32.
Da Silva PEA and Palomino JC. 2011. Molecular basis and mechanisms of drug
resistance in Mycobacterium tuberculosis: classical and new drugs. Journal of
Antimicrobial Chemotherapy. vol. 66. pp. 1417-1430.
Davila J, Zhang L, Marrs CF, Durmaz R, Yang Z. 2010. Assessment of the genetic
diversity of Mycobacterium tuberculosis esxA,esxH, and fbpB genes among
clinical isolates and its implication for the future immunization by new
tuberculosis subunit vaccines Ag85B-ESAT-6 and Ag85B-TB10.4. Journal of
Biomedicine and Biotechnology. vol. 2010. pp. 208371.
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
DISERTASI PROFIL RESPONS IMUN ... DESAK NYOMAN SURYA SUAMEITRIA DEWI
-
155
de Araujo LS, da Silva N deBM, Leung JAM, Mello FCQ, Saad MHF. 2018. IgG
subclasses' response to a set of mycobacterial antigens in different stages of
Mycobacterium tuberculosis infection. Tuberculosis. vol. 108. pp. 70-76.
Dembic Z. 2015. The cytokines of the immune system the role of cytokines in disease
related to immune response. Elsevier. United States.
Demir Y and Beydemir S. 2015. Purification, refolding, and characterization of
recombinant human paraoxonase-1. Turkish Journal of Chemistry. vol. 39. pp.
764-776.
Dewi DNSS, Soedarsono, Mertaniasih NM. 2018. T cell epitopes of the esxA full gene
of Mycobacterium tuberculosis from sputum of MDR-TB patients. African
Journal of Infectious Diseases. vol. 12. no. 2. pp. 66-70.
Diaclone. 2018. Instruction for use human IL-7 ELISA set. Diaclone. France. diakses
4 Februari 2019. https://www.diaclone.com/
Dieffenbach CW, Lowe TMJ, Dveksler GS. 1993. General consepts for pcr primer
design. Genome Research. vol. 3. pp. 30-37.
Dinas Kesehatan Jawa Timur. 2017. Profil kesehatan Provinsi Jawa Timur tahun 2016.
Dinas Kesehatan Provinsi Jawa Timur. Surabaya. diakses 4 November 2018.
http://www.depkes.go.id/resources/download/profil/PROFIL_KES_PROVINSI_
2016/15_Jatim_2016.pdf.
Dinas Kesehatan Kota Surabaya. 2017. Profil kesehatan Kota Surabaya tahun 2016.
Dinas Kesehatan Kota Surabaya. Surabaya. diakses 4 November 2018.
http://www.depkes.go.id/resources/download/profil/PROFIL_KAB_KOTA_201
6/3578_Jatim_Kota_Surabaya_2016.pdf.
Dotulong JFJ, Sapulete MR, Kandou GD. 2015. Hubungan faktor risiko umur, jenis
kelamin dan kepadatan hunian dengan kejadian penyakit TB paru di Desa Wori
Kecamatan Wori. Jurnal Kedokteran Komunitas dan Tropik. vol. III. no. 2. pp.
57-65.
Enos M, Sitienei J, Ong’ang’o J, Mungai B, Kamene M, Wambugu J, Kipruto H,
Manduku V, Mburu J, Nyaboke D, Ngari F, Omesa E, Omale N, Mwirigi N,
Okallo G, Njoroge J, Githiomi M, Mwangi M, Kirathe D, Kiplimo R, Ndombi A,
Odeny L, Mailu E, Kandie T, Maina M, Kasera K, Mulama B, Mugi B, Weyenga
H. 2018. Kenya tuberculosis prevalence survey 2016: challenges and opportunities
of ending TB in Kenya. Plos One. vol. 13. no. 12. pp. e0209098.
Falkinham JO. 1996. Epidemiology of infection by nontuberculous mycobacteria.
Clinical Microbiology Reviews. vol. 9. no. 2. pp. 177-215.
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
DISERTASI PROFIL RESPONS IMUN ... DESAK NYOMAN SURYA SUAMEITRIA DEWI
https://www.diaclone.com/http://www.depkes.go.id/resources/download/profil/PROFIL_KES_PROVINSI_2016/15_Jatim_2016.pdfhttp://www.depkes.go.id/resources/download/profil/PROFIL_KES_PROVINSI_2016/15_Jatim_2016.pdfhttp://www.depkes.go.id/resources/download/profil/PROFIL_KAB_KOTA_2016/3578_Jatim_Kota_Surabaya_2016.pdfhttp://www.depkes.go.id/resources/download/profil/PROFIL_KAB_KOTA_2016/3578_Jatim_Kota_Surabaya_2016.pdf
-
156
Fisher-Hoch SP, Whitney E, McCormick JB, Crespo G, Smith B, Rahbar MH,
Restrepo BI. 2008. Type 2 diabetes and multi-drug resistant tuberculosis.
Scandinavian Journal of Infectious Disease. vol. 40. no. 11-12. pp. 888-893.
Forrellad MA, Klepp LI, Gioffré A, García JSy, Morbidoni HR, Santangelo MdlP,
Cataldi AA, Bigi F. 2013. Virulence factors of the Mycobacterium tuberculosis
complex. Virulence. vol. 4. no. 1. pp. 3-66.
Franca LTC, Carrilho E, Kist TBL. 2002. A review of DNA sequencing techniques.
Quaterly Reviews of Biophysics. vol. 35. no. 2. pp. 169-200.
Fujita Y, Doi Takeshi, Maekura R, Ito M, Yano I. 2006. Differences in serological
responses to specific glycopeptidolipid-core and common lipid antigens in patients
with pulmonary disease due to Mycobacterium tuberculosis and Mycobacterium
avium complex. Journal of Medical Microbiology. vol. 55. pp. 189-199.
Garibyan L and Avashia N. 2013. Polymerase chain reaction. Journal of Investigative
Dermatology. vol. 133. pp. 1-4.
Gan SD and Patel KR. 2013. Enzyme immunoassay and enzyme-linked
immunosorbent assay. Journal of Investigative Dermatology. vol. 133. pp. e12
Gao J, Zhao L, Wan YY, Zhu B. 2015. Mechanism of Action of IL-7 and Its Potential
Applications and Limitations in Cancer Immunotherapy. International Journal of
Molecular Sciences. vol 16. no. 5. pp. 10267-10280.
Garrity GM, Bell JA, Lilburn TG. 2004. Taxonomic outline of the prokaryotes bergey’s
manual of systematic bacteriology second edition. Springer New York Inc. New
York.
Gennaro ML, Affouf M, Kanaujia GV, Brusasca PN, Mangaura B, Reichman L. 2007.
Antibody markers of incident tuberculosis among HIV-infected adults in the USA:
a historical prospective study. International Journal of Tuberculosis and Lung
Disease. vol. 11. no. 6. pp. 624-631.
Gersh JK, Feldman Z, Greenberger E, Chandra A, Friedman HM, Ho-Foster A, Haas
MK. 2018. Tuberculosis among individuals with community-acquired pneumonia
presenting to emergency in Gaborone, Botswana. Journal of Public Health in
Africa. vol. 9. no. 1. pp. 803.
Ghazawi FM, Faller EM, Sugden SM, Kakal JA, MacPherson PA. 2013. IL-7
downregulates IL-7Rα expression in human CD8 T cells by two independent
mechanisms. Immunology and Cell Biology. vol. 91. no. 2. pp. 149-158.
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
DISERTASI PROFIL RESPONS IMUN ... DESAK NYOMAN SURYA SUAMEITRIA DEWI
-
157
Green DA, Whittier S, Greendyke W, Win C, Chen X, Hamele-Bena D. 2016. Outbreak
of rapidly growing Nontuberculous Mycobacteria among patients undergoing
cosmetic surgery in the Dominican Republic. Annals of Plastic Surgery. vol. 78.
no. 1. pp. 17-21.
Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland
SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von
Reyn CF, Wallace RJ, Winthrop K. 2007. An official ATS/IDSA statement:
diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.
American Journal of Respiratory and Critical Care Medicine. vol. 175. no. 4. pp.
367-416.
Griffith DE. 2019. Nontuberculous mycobacterial disease, a comprehensive approach
to diagnosis and management. Springer Nature Switzerland AG. Switzerland.
Guinn KM, Hickey MJ, Mathur SK, Zakel KL, Grotzke JE, Lewinsohn DM, Smith S,
Sherman DR. 2004. Individual RD1-region genes are required for export of
ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis. Molecular
Microbiology. vol. 51. no. 2. pp. 359-370.
Gumilar G, Supriyanti FMT, Siti HH. 2008. Bioteknologi modul. FPMIPA Universitas
Pendidikan Indonesia. Bandung.
Gupta RS, Lo B, Son J. 2018. Phylogenomics and comparative genomic studies
robustly support division of the genus Mycobacterium into an emended genus
Mycobacterium and four novel genera. Frontiers in Microbiology. vol. 9. pp. 67.
Hafez SA, Elhefnawy AM, Hatata EA, El Ganady AA, Ibrahiem MI. 2013. Detection
of extensively drug resistant pulmonary tuberculosis. Egyptian Journal of Chest
Diseases and Tuberculosis. vol. 62. no. 4. pp. 635-646.
Hasan NA, Epperson LE, Lawsin A, Rodger RR, Perkins KM, Halpin AL, Perry KA,
Moulton-Meissner H, Diekema DJ, Crist MB, Perz JF, Salfinger M, Daley CL,
Strong M. 2019. Genomic analysis of cardiac surgery–associated Mycobacterium
chimaera Infections, United States. Emerging Infectious Diseases. vol. 25. no. 3.
pp. 559-563.
Hatano S, Tamura T, Umemura M, Matsuzaki G, Ohara N, Yoshikai Y. 2016.
Recombinant Mycobacterium bovis bacillus Calmette–Guérin expressing Ag85B-
IL-7 fusion protein enhances IL-17A-producing innate γδ T cells. Vaccine. vol.
34. no. 22. pp. 2490-2495
Hemmati M, Seghatoleslam A, Rasti M, Ebadat S, Mosavari N, Habibagahi M, Taheri
M, Sardarian AR, Mostafavi-Pour Z. 2011. Expression and purification of
recombinant Mycobacterium tuberculosis (TB) antigens, ESAT-6, CFP-10 and
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
DISERTASI PROFIL RESPONS IMUN ... DESAK NYOMAN SURYA SUAMEITRIA DEWI
-
158
ESAT- 6/CFP-10 and their diagnosis potential for detection of TB Patients. Iran
Red Crescent Medical Journal. vol. 13. no. 8. pp. 556–563.
Hertz D and Schneider B. 2018. Sex differences in tuberculosis. Seminars in
Immunopathology. vol. 41. no. 2. pp. 225-237.
Hiza H, Fenner L, Hela J, Kuchaka D, Sasamalo M, Blauenfeldt T, Kibiki G, Kavishe
RA, Mhimbira F, Ruhwald M. 2018. Boosting effect of IL-7 in interferon gamma
release assays to diagnose Mycobacterium tuberculosis infection. PLoS One. vol.
13. no. 8. pp. e0202525.
Holmberg V, Soini H, Kivelä P, Ollgren J, Ristola M. 2019. Epidemiology and
outcome of HIV patients in Finland co-infected with tuberculosis 1998–2015.
BMC Infectious Diseases. vol. 19. pp. 264.
Horton KC, MacPherson P, Houben RMGJ, White RG, Corbett EL. 2016. Sex
differences in tuberculosis burden and notifications in low- and middle-income
countries: a systematic review and meta-analysis. Plos Medicine. vol. 13. no. 9.
pp. e1002119.
Howe C. 2007. Gene cloning and manipulation. Cambridge University Press. New
York.
Huang T, Wu K, Yuan X, Shao S, Wang WY, Wei S. 2016. Molecular analysis of the
immunoglobulin genes in goose. Developmental and Comparative Immunology.
vol. 60. pp. 160-166.
Huang H, Wang F, Yang E, Wang H, Gao P, Shen H. 2018. Assessment of recombinant
plasmid expressing fusion antigen Ag85B-Rv3425 in management of acute
tuberculosis infection in mice. Experimental and Therapeutic Medicine. vol. 15.
no. 3. pp. 3034-3039.
Hutchison III CA. 2007. DNA sequencing: bench to bedside and beyond. Nucleic Acid
Research. vol. 35. no. 18. pp. 6227-6237.
Idexx. 2013. ELISA technical guide. IDEXX Laboratories Inc. USA. diakses 20
Desember 2017. https://www.idexx.eu/slovakia/education/articles/elisa-
technical-guide/
Jacob RF. 1994. Multiple-drug-resistant tuberculosis. Clinical Infectious Diseases. vol.
19. pp. 1-10.
Jacobs AJ, Mongkolsapaya J, Screaton GR, McShane H, Wilkinson RJ. 2016.
Antibodies and tuberculosis. Tuberculosis. vol. 101. pp. 102-113.
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
DISERTASI PROFIL RESPONS IMUN ... DESAK NYOMAN SURYA SUAMEITRIA DEWI
https://www.idexx.eu/slovakia/education/articles/elisa-technical-guide/https://www.idexx.eu/slovakia/education/articles/elisa-technical-guide/
-
159
Jensen EC. 2012. The basics of western blotting. The Anatomical Record. vol. 295. pp.
369-371.
Kaufmann SHE. 2004. New issues in tuberculosis. Annals of the Rheumatic Diseases.
vol. 63. no. 2. pp. 50-56.
Kefala G and Weiss MS. 2006. Cloning, expression, purification, crystallization and
preliminary X-ray diffraction analysis of DapA (Rv2753c) from Mycobacterium
tuberculosis. Acta Crystallization. vol. F62. no.11. pp. 1116-1119.
Kementerian Kesehatan RI Direktorat Jenderal Pengendalian Penyakit dan Penyehatan
Lingkungan. 2014. Pedoman nasional pengendalian tuberkulosis. Kementerian
Kesehatan RI. Jakarta. diakses 26 September 2015.
http://spiritia.or.id/dokumen/pedoman-tbnasional2014.pdf.
Kementerian Kesehatan RI (InfoDATIN: Pusat Data dan Informasi Kementerian
Kesehatan). 2016. Tuberkulosis temukan, obati sampai sembuh. PUSDATIN.
Jakarta. diakses 12 Januari 2017. www.depkes.go.id.
Kementerian Kesehatan RI. 2017. Data dan informasi profil kesehatan Indonesia 2016.
Pusat Data dan Informasi Kementerian Kesehatan RI. Jakarta. diakses 4 Januari
2018. http://www.depkes.go.id/resources/download/pusdatin/lain-
lain/Data%20dan%20Informasi%20Kesehatan%20Profil%20Kesehatan%20Indo
nesia%202016%20-%20%20smaller%20size%20-%20web.pdf.
Kementerian Kesehatan RI (InfoDATIN: Pusat Data dan Informasi Kementerian
Kesehatan). 2018a. Tuberkulosis. PUSDATIN. Jakarta. diakses 4 Januari 2019.
www.depkes.go.id
Kementerian Kesehatan RI. 2018b. Data dan informasi profil kesehatan Indonesia
2017. Pusat Data dan Informasi Kementerian Kesehatan RI. Jakarta. diakses 4
November 2018
http://www.pusdatin.kemkes.go.id/resources/download/pusdatin/profil-
kesehatan-indonesia/Data-dan-Informasi_Profil-Kesehatan-Indonesia-2017.pdf
Kim EJ, Kim EB, Lee SW, Cheon SA, Kim HJ, Lee J, Lee MK, Ko S, Park TJ. 2017.
An easy and sensitive sandwich assay for detection of Mycobacterium
tuberculosis Ag85B antigen using quantum dots and gold nanorods. Biosensors
and Bioelectronics. vol. 87. pp. 150-156.
Kitada S, Maekura R, Toyoshima N, Fujiwara N, Yano I, Ogura T, Ito M, Kobayashi
K. 2002. Serodiagnosis of pulmonary disease due to Mycobacterium avium
complex with an enzyme immunoassay that uses a mixture of glycopeptidolipid
antigens. Clinical Infectious Diseases. vol. 35. no 11. pp. 1328–1335.
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
DISERTASI PROFIL RESPONS IMUN ... DESAK NYOMAN SURYA SUAMEITRIA DEWI
http://spiritia.or.id/dokumen/pedoman-tbnasional2014.pdfhttp://www.depkes.go.id/http://www.depkes.go.id/resources/download/pusdatin/lain-lain/Data%20dan%20Informasi%20Kesehatan%20Profil%20Kesehatan%20Indonesia%202016%20-%20%20smaller%20size%20-%20web.pdfhttp://www.depkes.go.id/resources/download/pusdatin/lain-lain/Data%20dan%20Informasi%20Kesehatan%20Profil%20Kesehatan%20Indonesia%202016%20-%20%20smaller%20size%20-%20web.pdfhttp://www.depkes.go.id/resources/download/pusdatin/lain-lain/Data%20dan%20Informasi%20Kesehatan%20Profil%20Kesehatan%20Indonesia%202016%20-%20%20smaller%20size%20-%20web.pdfhttp://www.depkes.go.id/http://www.pusdatin.kemkes.go.id/resources/download/pusdatin/profil-kesehatan-indonesia/Data-dan-Informasi_Profil-Kesehatan-Indonesia-2017.pdfhttp://www.pusdatin.kemkes.go.id/resources/download/pusdatin/profil-kesehatan-indonesia/Data-dan-Informasi_Profil-Kesehatan-Indonesia-2017.pdf
-
160
Kitada S, Maekura R, Toyoshima N, Naka T, Fujiwara N, Kobayashi M, Yano I, Ito
M, Kobayashi K. 2005. Use of glycopeptidolipid core antigen for serodiagnosis of
Mycobacterium avium complex pulmonary disease in immunocompetent patients.
Clinical and Diagnostic Laboratory Immunology. vol. 12. no. 1. pp. 44-51.
Kitada S, Kobayashi K, Ichiyama S, Takakura S, Sakatani M, Suzuki K, Takashima T,
Nagai T, Sakurabayashi I, Ito M, Maekura R. 2008. Serodiagnosis of
Mycobacterium avium–complex pulmonary disease using an enzyme
immunoassay kit. American Journal of Respiratory and Critical Care Medicine.
vol. 177. no. 7. pp. 793–797.
Kitada S, Levin A, Hiserote M, Harbeck RJ, Czaja CA, Huitt G, Kasperbauer SH,
Daley CL. 2013. Serodiagnosis of Mycobacterium avium complex pulmonary
disease in the USA. European Respiratory Journal. vol. 42. no. 2. pp. 454–460.
Kitada S, Maekura R, Yoshimura K, Miki K, Miki M, Oshitani Y, Nishida K, Sawa N,
Mori M, Kobayashi K. 2017. Levels of antibody against glycopeptidolipid core as
a Marker for monitoring treatment response in Mycobacterium avium complex
pulmonary disease: a prospective cohort study. Journal Clinical Microbiology.
vol. 55. no. 3. pp. 884–892.
Korotkova N, Piton J, Wagner JM, Boy-Röttger S, Aleksandre J, Evans TJ, Cole ST,
Pojer F, Korotkov KV. 2015. Structure of EspB, a secreted substrate of the ESX-
1 secretion system of Mycobacterium tuberculosis. Journal of Structural Biology.
vol. 191. pp. 236-244.
Lande L, Alexander DC, Wallace RJ, Kwait RJ, Iakhiaeva E, Williams M, Cameron
ADS, Olshefsky S, Devon R, Vasireddy R, Peterson DD, Falkinham JO. 2019.
Mycobacterium avium in community and household water, suburban Philadelphia,
Pennsylvania, USA, 2010 – 2012. Emerging Infectious Diseases. vol. 25. no. 3.
pp. 473–481.
Larrea E, Riezu-Boj J-I, Aldabe R, Guembe L, Echeverria I, Balasiddaiah A,
Gastaminza P, Civeira MP, Sarobe P, Prieto J. 2014. Dysregulation of interferon
regulatory factors impairs the expression of immunostimulatory molecules in
hepatitis C virus genotype 1-infected hepatocytes. Gut. vol. 63. no. 4. pp. 665-673.
Lee CD, Sun HC, Hu SM, Chiu CF, Homhuan A, Liang SM, Leng CH, Wang TF.
2008. An improved SUMO fusion protein system for effective production of
native proteins. Protein Science. vol. 17. pp. 1241-1248.
Lemeshow S, Hosmer DW, Klar J, Lwanga SK. 1990. Adequacy of sample size in
health studies. John Wiley & Sons Ltd. West Sussex.
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
DISERTASI PROFIL RESPONS IMUN ... DESAK NYOMAN SURYA SUAMEITRIA DEWI
-
161
Lin AV. 2015. Indirect ELISA. In: Hnasko R. (eds) ELISA. Methods in molecular
biology vol 1318. Humana Press. New York.
Liu Y, Zhang X, Zhang Y, Sun Y, Yao C, Wang W, Li C. 2018. Characterization of
Mycobacterium tuberculosis strains in Beijing, China: drug susceptibility
phenotypes and Beijing genotype family transmission. BMC Infectious Diseases.
vol. 18. no. 1. pp. 658.
López-Varela E, García-Basteiro AL, Augusto OJ, Fraile O, Bulo H, Ira T, Gondo K,
van Ingen J, Naniche D, Sacarlal J, Alonso PL. 2017. Correction: high rates of
non-tuberculous mycobacteria isolation in Mozambican children with
presumptive tuberculosis. PLoS One. vol. 12. no. 1. pp. e0175613.
Lu Y, Xu Y, Yang E, Wang C, Wang H, Shen H. 2012. Novel recombinant BCG
coexpressing Ag85B, ESAT-6 and Rv2608 elicits significantly enhanced cellular
immune and antibody responses in C57BL⁄6 Mice. Basic Immunology. vol. 76. no.
3. pp. 271-277.
Lundtoft C, Afum-Adjei Awuah A, Rimpler J, Harling K, Nausch N, Kohns M,
Adankwah E, Lang F, Olbrich L, Mayatepek E, Owusu-Dabo E, Jacobsen M.
2017. Aberrant plasma IL-7 and soluble IL-7 receptor levels indicate impaired T-
cell response to IL-7 in human tuberculosis. Plos Pathogens. vol. 13. no. 6. pp.
e1006425.
Lundtoft C, Afum-Adjei Awuah A, Güler A, Harling K, Schaal H, Mayatepek E,
Phillips RO, Nausch N, Owusu-Dabo E, Jacobsen M. 2018. An IL7RA exon 5
polymorphism is associated with impaired IL-7Rα splicing and protection against
tuberculosis in Ghana. Genes & Immunity. doi: 10.1038/s41435-018-0049-5.
Maekura R, Okuda Y, Nakagawa M, Hiraga T, Yokota S, Ito M, Yano I, Kohno H,
Wada M, Abe C, Toyoda T, Kishimoto T, Ogira T. 2001. Clinical Evaluation of
Anti-Tuberculous Glycolipid Immunoglobulin G Antibody Assay for Rapid
Serodiagnosis of Pulmonary Tuberculosis. Journal of Clinical Microbiolgy. vol.
39. no. 10. pp. 3603-3608
Mahboub BH and Vats MG. 2013. Tuberculosis-current issues in diagnosis and
management, InTech. Croatia. diakses 14 Maret 2016.
http://www.intechopen.com/books/tuberculosis-current-issues-in-diagnosis-and-
management.
Mahmood T and Yang PC. 2012. Western blot: technique, theory, and trouble shooting.
North American Journal of Medical Science. vol. 4. no. 9. pp. 429-434.
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
DISERTASI PROFIL RESPONS IMUN ... DESAK NYOMAN SURYA SUAMEITRIA DEWI
http://www.intechopen.com/books/tuberculosis-current-issues-in-diagnosis-and-managementhttp://www.intechopen.com/books/tuberculosis-current-issues-in-diagnosis-and-management
-
162
Mekonnen F, Tessema B, Moges F, Gelaw A, Eshetie S, Kumera G. 2015. Multidrug
resistant tuberculosis: prevalence and risk factors in districts of metema and west
armachiho, Northwest Ethiopia. BMC Infectious Diseases. vol. 15. pp. 461.
Mertaniasih NM, Koendhori EB, Kusumaningrum D. 2013a. Tuberkulosis diagnostik
mikrobiologis. Airlangga University Press (AUP). Surabaya.
Mertaniasih NM, Wiqoyah N, Kuntaman, Wahyunitisari MR, Kusumaningrum D.
2013b. Polymerase chain reaction of Mycobacterium tuberculosis gyrb gene
region for rapid screening test of pulmonary tuberculosis. Folia Medica
Indonesiana. vol. 49. no. 1. pp. 16-20.
Mertaniasih NM, Kusumaningrum D, Koendhori EB, Soedarsono, Kusmiati T, Dewi
DNSS. 2017. Nontuberculous mycobacterial species and Mycobacterium
tuberculosis complex coinfection in patients with pulmonary tuberculosis in Dr.
Soetomo Hospital, Surabaya, Indonesia. The International Journal of
Mycobacteriology. vol. 6. no. 1. pp. 9-13.
Miltgen J, Morillon M, Koeck JL, Varnerot A, Briant JF, Nguyen G, Verrot D, Bonnet
D, Vincent V. 2002. Two cases of pulmonary tuberculosis caused by
Mycobacterium tuberculosis subsp. canetti. Emerging Infectious Diseases. vol. 8.
no. 11. pp. 1350-1352.
Mulisa G, Workneh T, Hordofa N, Suaudi M, Abebe G, Jarso G. 2015. Multidrug-
resistant Mycobacterium tuberculosis and associated risk factors in Oromia
Region of Ethiopia. International Journal of Infectious Diseases. vol. 39. pp. 57-
61.
Munshi A. 2012. DNA sequencing – methods and applications. InTech. Croatia.
Nagai S, Wiker HG, Harboe M, Kinomoto M. 1991. Isolation and partial
characterization of major protein antigens in the culture fluid of Mycobacterium
tuberculosis. Infection and Immunity. vol. 59. no. 1. pp. 372-382.
NCBI. 2016. esxA ESAT-6 protein EsxA [Mycobacterium tuberculosis H37Rv]. diakses
14 April 2016. https://www.ncbi.nlm.nih.gov/gene/886209.
NIAID. 2007. Research agenda multidrug resistant and extensively drug-resistant
tuberculosis. NIAID Tuberculosis Working Group. diakses 14 Maret 2016.
http://www.niaid.nih.gov/topics/tuberculosis/research/documents/mdrxdrresearc
hagenda.pdf
Niki M, Suzukawa M, Akashi S, Nagai H, Ohta K, Inoue M, Niki M, Kaneko Y,
Morimoto K, Kurashima A, Kitada S, Matsumoto S, Suzuki K, Hoshino Y. 2015.
Evaluation of humoral immunity to Mycobacterium tuberculosis-specific antigens
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
DISERTASI PROFIL RESPONS IMUN ... DESAK NYOMAN SURYA SUAMEITRIA DEWI
https://www.ncbi.nlm.nih.gov/gene/886209http://www.niaid.nih.gov/topics/tuberculosis/research/documents/mdrxdrresearchagenda.pdfhttp://www.niaid.nih.gov/topics/tuberculosis/research/documents/mdrxdrresearchagenda.pdf
-
163
for correlation with clinical status and effective vaccine development. Journal of
Immunology Research. vol. 2015. ID 527395.
Nowakowski AB, Wobig WJ, Petering DH. 2014. Native SDS-PAGE: high resolution
electrophoretic separation of proteins with retention of native properties including
bound metal ions. Metallomics. vol. 6. no. 5. pp. 1068-1078.
Ogbo FA, Ogeleka P, Okoro A, Olusanya BO, Olusanya J, Ifegwu IK, Awosemo AO,
Eastwood J, Page A. 2018. Tuberculosis disease burden and attributable risk
factors in Nigeria, 1990–2016. Tropical Medicine and Health. vol. 46. pp. 34.
O’Gorman MRG and Donnenberg AD. 2008. Handbook of Human Immunology 2nd
edition. CRC Press (Taylor & Francis Group). USA.
Okkels LM and Andersen P. 2004. Protein-protein interactions of proteins from the
esat-6 family of Mycobacterium tuberculosis. Society. vol. 186. no. 8. pp. 2487-
2491.
Osada-Oka M, Tateishi Y, Hirayama Y, Ozeki Y, Niki M, Kitada S, Maekura R,
Tsujimura K, Koide Y, Ohara N, Yamamoto T, Kobayashi K, Matsumoto S. 2013.
Antigen 85A and mycobacterial DNA-binding protein 1 are targets of
immunoglobulin G in individuals with past tuberculosis. Microbiology
Immunology. vol. 57. pp. 30-37.
Owen JA, Punt J, Stranford SA. 2007. Kuby immunology 5th ed. W. H. Freeman and
Company. United States of America.
Owen JA, Punt J, Stranford SA. 2013. Kuby immunology 7h ed. W. H. Freeman and
Company. United States of America.
Palma C, Iona E, Giannoni F, Pardini M, Brunori L, Orefici G, Fattorini L, Cassone A.
2007. The Ag85B protein of Mycobacterium tuberculosis may turn a protective
immune response induced by Ag85B-DNA vaccine into a potent but non-
protective Th 1 immune response in mice. Cellular Microbiology. vol. 9. no. 6.
pp. 1455-1465.
Parija SC. 2012. Textbook of microbiology & immunology 2nd edition. Reed Elsevier
India Private Limited. New Delhi.
Pathak SK, Basu S, Basu KK, Banerjee A, Pathak S, Bhattacharyya A, Kaisho T,
Kundu M, Basu J. 2007. Direct extracellular interaction between the early secreted
antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling
in macrophages. Nature Immunology. vol. 8. no. 6. pp. 610-618.
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
DISERTASI PROFIL RESPONS IMUN ... DESAK NYOMAN SURYA SUAMEITRIA DEWI
-
164
Perez EE, Orange JS, Bonilla F, Chinen J, Chinn IK, Dorsey M, El-Gamal Y, Harville
TO, Hossny E, Mazer B, Nelson R, Secord E, Jordan SC, Richard S, Vo AA,
Ballow M. 2017. Update on the use of immunoglobulin in human disease: A
review of evidence. Journal of Allergy and Clinical Immunology. vol. 139. no. 3.
pp. S1-S46.
Perumal R, Naidoo K, Padayatchi N. 2018. TB epidemiology: where are the young
women? Know your tuberculosis epidemic, know your response. BMC Public
Health. vol. 18. no. 1. pp. 417
Playfair JHL and Chain BM. 2012. At a glance imunologi edisi kesembilan. Erlangga.
Jakarta.
Prakash R, Kumar D, Gupta VK, Jain S, Chauhan DS, Tiwari PK, Katoch VM. 2016.
Status of multidrug resistant tuberculosis (MDR-TB) among the Sahariya tribe of
North Central India. Journal of Infection and Public Health. vol. 9. no. 3 pp. 289-
297.
Rane L, Rahman S, Magalhaes I, Ahmed R, Spangberg M, Kondova I, Verreck F,
Andersson J, Brighenti S, Maeurer MJ. 2011. Increased (6 exon) interleukin-7
production after M. tuberculosis infection and soluble interleukin-7 receptor
expression in lung tissue. Genes and Immunity. vol. 12. pp. 513-522.
Rashak HA, Sánchez-Pérez HJ, Abdelbary BE, Bencomo-Alerm A, Enriquez-Ríos N,
Gómez-Velasco A, Colorado A, Castellanos-Joya M, Rahbar MH, Restrepo BI.
2019. Diabetes, undernutrition, migration and indigenous communities:
tuberculosis in Chiapas, Mexico. Epidemiology and Infection. vol. 147. pp. e71.
Roy S and Kumar V. 2012. A Practical approach on SDS PAGE for separation of
protein. International Journal of Science and Research. vol. 3. no. 8. pp. 955-960.
Rodríguez-Ezpeleta N, Hackenberg M, Aransay AM. 2012. Bioinformatics for high
throughput sequencing. Springer Science+Business Media. New York.
Rogerson BJ, Jung YJ, LaCourse R, Ryan L, Enright N, North RJ. 2006. Expression
levels of Mycobacterium tuberculosis antigen-encoding genes versus production
levels of antigen-specific T cells during stationary level lung infection in mice.
Immunology. vol. 118. no. 2. pp. 195-201.
Rudolf F, Joaquim LC, Vieira C, Bjerregaard-Andersen M, Andersen A, Erlandsen M,
Sodemann M, Andersen PL, Wejse C. 2013. The Bandim tuberculosis score:
reliability and comparison with the Karnofsky performance score. Scandinavian
Journal of Infectious Diseases. vol. 45. pp. 256-264.
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
DISERTASI PROFIL RESPONS IMUN ... DESAK NYOMAN SURYA SUAMEITRIA DEWI
-
165
Rudolf F. 2014. The Bandim TBscore - reliability, further development, and evaluation
of potential uses. Global Health Action. vol. 7. pp. 24303.
Rudolf F, Wagner AJ, Back FM, Gomes VF, Aaby P, Østergaard L, Eugen-Olsen J,
Wejse C. 2017. Tuberculosis case finding and mortality prediction: added value
of the clinical TBscore and biomarker suPAR. The International Journal of
Tuberculosis and Lung Disease. vol. 21. no. 1. pp. 67-72.
Sagwa EL, Mantel-Teeuwisse AK, Ruswa NC. 2014. Occurrence and clinical
management of moderate-to-severe adverse events during drug-resistant
tuberculosis treatment: a retrospective cohort study, Journal of Pharmaceutical
Policy and Practice. vol. 7. no. 1. pp. 14.
Sambrook J and Russel DW. 2001. Molecular cloning, a laboratory manual, 3th
edition, volume 2. Cold Spring Harbor Laboratory Press. USA.
Sanger F. 1981. Sequences in DNA. Science. vol. 214. pp. 1205-1210.
Schluger NW. 2007. Tuberculosis and non-tuberculous mycobacterial infections in
older adults. Clinics in Chest Medicine. vol. 28. no. 4. pp. 773-781.
Schorey JS and Sweet L. 2008. The mycobacterial glycopeptidolipids: structure,
function, and their role in pathogenesis. Glycobiology. vol. 18. no. 11. pp. 832-
842.
Schroeder HW and Cavacini L. 2010. Structure and function of immunoglobulins.
Journal Allergy Clinical Immunology. vol. 125. no. 2. pp. 41-52.
Schuller M, Sloots TP, James GS, Halliday CL, Carter IWJ. 2010. PCR for clinical
microbiology an australian and international perspective. Springer
Science+Business Media. New York.
Sharma SK and Mohan A. 2004. Multidrug-resistant tuberculosis. Indian Journal
Medical Research. vol. 120. pp. 354-376.
Silva VMC, Kanaujia G, Gennaro ML, Menzies D. 2003. Factors associated with
humoral response to ESAT-6, 38 kDa and 14 kDa in patients with a spectrum of
tuberculosis. International Journal of Tuberculosis and Lung Disease. vol. 7. no.
5. pp. 478-484.
Simeone R, Bottai D, Frigui W, Majlessi L, Brosch R. 2015. ESX/type VII secretion
systems of mycobacteria: Insights into evolution, pathogenicity and protection.
Tuberculosis. vol. 95. pp. 150-154.
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
DISERTASI PROFIL RESPONS IMUN ... DESAK NYOMAN SURYA SUAMEITRIA DEWI
-
166
Simonney B, Chavanet P, Perronne C, Leportier M, Revol F, Herrmann JL, Lagrange
PH. 2007. B-cell immune responses in HIV positive and HIV negative patients
with tuberculosis evaluated with an ELISA using a glycolipid antigen.
Tuberculosis. vol. 87. pp. 109-112.
Singh S, Gopinath K, Shahdad S, Kaur M, Singh B, Sharma P. 2007. Nontuberculous
mycobacterial infection in Indian AIDS patients detected by a novel set of ESAT-
6 polymerase chain reaction primers. Japanese Journal of Infectious Disease. vol.
60. no. 1. pp.14-18.
Singleton P. 2000. DNA methods in clinical microbiology. Springer Science+Business
Media. Dordrecht.
Soedarsono. 2015. Asosiasi polimorfsme gen TLRs dengan derajat keparahan penyakit
pasien tb paru mdr dan peran sekuens gen esxA. Disertasi. Program Studi Ilmu
Kedokteran Jenjang Doktor. Fakultas Kedokteran Universitas Airlangga.
Soedarto. 2015. Mikrobiologi Kedokteran. Sagung Seto. Jakarta.
Solans L, Aguiló N, Samper S, Pawlik A, Frigui W, Martín C, Brosch R, Gonzalo-Asensio
J. 2014. A specific polymorphism in Mycobacterium tuberculosis H37Rv causes
differential ESAT-6 expression and identifies WhiB6 as a novel ESX-1 component.
Journal of Infection and Immunity. vol. 82. no. 8. pp. 3446-3456.
Steingart KR, Dendukuri N, Henry M, Schiller I, Nahid P, Hopewell PC, Ramsay A, Pai M,
Laal S. 2009. Performance of purified antigens for serodiagnosis of pulmonary
tuberculosis: a meta-analysis. Clinical and Vaccine Immunology. vol. 16. no. 2. pp. 260-
276.
Stevenson CR, Crithchley JA, Forouhi NG, Roglic G, Williams BG, Dye C, Unwin
NC. 2007. Diabetes and the risk of tuberculosis: a neglected threat to public
health?. Chronic Illness. vol. 3. no. 3. pp. 228-245.
Sudre P, Dam GT, Kochi A. 1992. Tuberculosis: a global overview of the situation
today. Bulletin of The World Health Organization. vol. 70. no. 2. pp. 149-159.
Surkova L, Horevich HL, Titov LP, Sahalchyk E, Arjomandzadegan M, Alinejad S,
Sadrnia M. 2012. A study on demographic characteristics of drug resistant
Mycobacterium tuberculosis isolates in Belarus. International Journal of
Mycobacteriology. vol. I. no. 2. pp. 75-81.
Takei F and Nakatani K. 2013. The chemistry of pcr primers: concept and application.
Israel Journal of Chemistry. vol. 53. pp. 1-16.
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
DISERTASI PROFIL RESPONS IMUN ... DESAK NYOMAN SURYA SUAMEITRIA DEWI
-
167
Tan Y, Su B, Shu W, Cai X, Kuang S, Kuang H, Liu J, Pang Y. 2018. Epidemiology
of pulmonary disease due to nontuberculous mycobacteria in Southern China,
2013–2016. BMC Pulmonary Medicine. vol. 18. pp. 168.
Taniguchi K, Takii T, Yamamoto S, Maeyama JI, Iho S, Maruyama M, Iizuka N, Ozeki
Y, Matsumoto S, Hasegawa T, Miyatake Y, Itoh S, Onozaki K. 2013. Reactivation
of immune responses against Mycobacterium tuberculosis by boosting with the
CpG oligomer in aged mice primarily vaccinated with Mycobacterium bovis BCG.
Immunity & Ageing. vol. 10. pp. 25.
Tape TG. 2000. Using the receiver operating characteristic (ROC) curve to analyze a
classification model. University of Nebraska Medical Center. diakses 19 Oktober
2018. http://gim.unmc.edu/dxtests/effect1.htm.
Tasbiti AH, Yari S, Ghanei M, Shokrgozar MA, Fateh A, Bahrmand A. 2017. Low
level of extensively drug-resistant tuberculosis among MDR-TB isolates and its
relationship to risk factors: surveillance in Tehran-Iran. Osong Public Health
Research Perspective. vol. 8. no. 2. pp. 116-123.
TB Database. 2010. Rv3875-6 kda early secretory antigenic target esxA. diakses 14
April 2016. http://genome.tbdb.org/cgi-bin/GeneDetails.html?id=SRv3875.
Tegegne BS, Habtewold TD, Mengesha MM, Burgerhof GM. 2017. Association
between diabetes mellitus and multi-drug-resistant tuberculosis: a protocol for a
systematic review and meta-analysis. Systematic Reviews. vol. 2017. no. 6. pp. 1-
5.
Terrazzini N, Mantegani P, Kern F, Fortis C, Mondino A, Caserta S. 2018. Interleukin-
7 unveils pathogen-specific T Cells by enhancing antigen-recall responses.
Journal of Infectious Diseases. vol. 217. no 12. pp. 1997-2007.
Teutschbein J, Schumann G, Möllmann U, Grabley S, Cole ST, Munder T. 2009. A
protein linkage map of the ESAT-6 secretion system 1(ESX-1) of Mycobacterium
tuberculosis. Microbiological Resarch. vol. 164. pp. 253-259.
Thang PH, Ruffin N, Brodin D, Rethi B, Cam PD, Hien NT, Lopalco L, Vivar N,
Chiodi F. 2010. The role of IL-1β in reduced IL-7 production by stromal and
epithelial cells: a model for impaired T-cell numbers in the gut during HIV-1
infection. Journal of Internal Medicine. vol. 268. no. 2. pp. 181-193.
Tille PM. 2014. Bailey & scott’s diagnostic microbilogy 13th edition. Elsevier Mosby.
Missouri.
Tipu HN and Shabbir A. 2015. Evolution of DNA sequencing. Journal of the College
of Physicians and Surgeons Pakistan. vol. 25. no. 3. pp. 210-215.
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
DISERTASI PROFIL RESPONS IMUN ... DESAK NYOMAN SURYA SUAMEITRIA DEWI
http://gim.unmc.edu/dxtests/effect1.htmhttp://genome.tbdb.org/cgi-bin/GeneDetails.html?id=SRv3875
-
168
Todar K. 2012 Mycobacterium tuberculosis and tuberculosis. diakses 25 Maret 2016.
http://textbookofbacteriology.net/tuberculosis.html
Tuberculist. 2013. fbpB. diakses 28 Maret 2018.
http://svitsrv8.epfl.ch/tuberculist/quicksearch.php?gene+name=fbpB&submit=Se
arch
Tullius MV, Harth G, Masleša-Galić S, Dillon BJ, Horwitz MA. A replication-limited
recombinant Mycobacterium bovis BCG vaccine against tuberculosis designed for
human immunodeficiency virus-positive persons is safer and more efficacious
than BCG. Infection and Immunity. vol. 76, no. 11. pp. 5200-5214.
Turner RD and Bothamley GH. 2015. Cough and the transmission of tuberculosis. The
Journal of Infectious Diseases. vol. 211. no. 9. pp. 1367-1372.
Ugarte-Gil C, Alisjahbana B, Ronacher K, Riza AL, Koesoemadinata RC, Malherbe
ST, Cioboata R, Llontop JC, Kleynhans L, Lopez S, Santoso P, Marius C,
Villaizan K, Ruslami R, Walzl G, Panduru NM, Dockrell HM, Hill PC, Mc
Allister S, Pearson F, Moore DAJ, Critchley JA, van Crevel R. 2019. Diabetes
mellitus among pulmonary tuberculosis patients from four TB-endemic countries:
the TANDEM study. Clinical Infectious Diseases. ciz284. doi:
10.1093/cid/ciz284.
Uplekar S, Heym B, Friocourt V, Rougemont J, Cole ST. 2011. Comparative genomics
of esx genes from clinical isolates of Mycobacterium tuberculosis provides
evidence for gene conversion and epitope variation. Journal Infection and
Immunity. vol. 79. no. 10. pp. 4042-4049.
van Crevel R, Ottenhoff THM and van der Meer JWM. 2002. Innate immunity to
Mycobacterium tuberculosis. Clinical Microbiology Reviews. vol. 15. no. 2. pp.
294-309.
Virenfeldt J, Rudolf F, Camara C, Furtado A, Gomes V, Aaby P, Petersen E, Wejse C,
2014. Treatment delay affects clinical severity of tuberculosis: a longitudinal
cohort study. BMJ Open. vol. 4. pp. e004818.
Wakabayashi K. 2010. ELISA- A to Z from introduction to practice. Shibayagi Co Ltd.
Jepang.
Walker JM. 2002. Protein protocols handbook second edition. Humana Press Inc.
United States of America.
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
DISERTASI PROFIL RESPONS IMUN ... DESAK NYOMAN SURYA SUAMEITRIA DEWI
http://textbookofbacteriology.net/tuberculosis.htmlhttp://svitsrv8.epfl.ch/tuberculist/quicksearch.php?gene+name=fbpB&submit=Searchhttp://svitsrv8.epfl.ch/tuberculist/quicksearch.php?gene+name=fbpB&submit=Searchhttps://doi.org/10.1093/cid/ciz284https://doi.org/10.1093/cid/ciz284
-
169
Weber K and Osborn M. 1969. The reliability of molecular weight determinations by
dodecyl sulfate-polyacrylamide gel electrophoresis. The Journal of Biological
Chemistry. vol. 244. no. 16. pp. 4406-4412.
WHO. 2010. Multidrug and extensively drug-resistant tb (m/xdr-tb) 2010 global
report on surveillance and response. World Health Organization. Geneva.
diakses tanggal 14 Maret 2016.
http://apps.who.int/iris/bitstream/10665/44286/1/9789241599191_eng.pdf.
WHO. 2014. Global tuberculosis report 2014. World Health Organization. Geneva.
diakses 14 Januari 2016. http://www.who.int/tb/country/en/.
WHO. 2015a. Implementation tuberculosis diagnostics. World Health Organization.
Geneva. diakses 17 Juni 2016.
http://apps.who.int/iris/bitstream/10665/162712/1/9789241508612_eng.pdf
WHO. 2015b. Tuberculosis control in the South-East Asia region. World Health
Organization. Geneva. diakses 1 Desember 2015.
http://www.searo.who.int/tb/annual-tb-report-2015.pdf.
WHO. 2015c. Global tuberculosis report 2015. World Health Organization. Geneva.
diakses 1 Desember 2015.
http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf?ua=
1.
WHO. 2016a. Global tuberculosis report 2016. World Health Organization. Geneva.
diakses 12 Januari 2017.
http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf?ua=1
WHO. 2016b. Tuberculosis control in the South-East Asia Region. World Health
Organization. Geneva. diakses 4 Januari 2018.
http://apps.who.int/iris/handle/10665/205286
WHO. 2016c. WHO treatment guidelines for drug-resistant tuberculosis. World Health
Organization. Geneva. diakses 26 September 2016.
http://www.who.int/tb/MDRTBguidelines2016.pdf.
WHO. 2017. Global tuberculosis report 2017. World Health Organization. Geneva.
diakses 7 Desember 2017.
http://apps.who.int/iris/bitstream/10665/259366/1/9789241565516-eng.pdf?ua=1
WHO. 2018. Global tuberculosis report 2018. World Health Organization. Geneva.
diakses 30 September 2018.
https://apps.who.int/iris/bitstream/handle/10665/274453/9789241565646-
eng.pdf?ua=1
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
DISERTASI PROFIL RESPONS IMUN ... DESAK NYOMAN SURYA SUAMEITRIA DEWI
http://apps.who.int/iris/bitstream/10665/44286/1/9789241599191_eng.pdfhttp://www.who.int/tb/country/en/http://apps.who.int/iris/bitstream/10665/162712/1/9789241508612_eng.pdfhttp://www.searo.who.int/tb/annual-tb-report-2015.pdfhttp://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf?ua=1http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf?ua=1http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf?ua=1http://apps.who.int/iris/handle/10665/205286http://www.who.int/tb/MDRTBguidelines2016.pdfhttp://apps.who.int/iris/bitstream/10665/259366/1/9789241565516-eng.pdf?ua=1https://apps.who.int/iris/bitstream/handle/10665/274453/9789241565646-eng.pdf?ua=1https://apps.who.int/iris/bitstream/handle/10665/274453/9789241565646-eng.pdf?ua=1
-
170
Yang H, Kruh-Garcia NA, Dobos KM. 2012. Purified Protein Derivatives of
Tuberculin - Past, Present, and Future. Medical Microbiology and Immunology.
vol. 66. no. 3. pp. 273-280.
You E, Kim M, Lee WI, Kang SY. 2016. Evaluation of IL-2, IL-10, IL-17 and IP-10
as potent discriminative markers for active tuberculosis among pulmonary
tuberculosis suspects. Tuberculosis. vol. 99. pp. 100-108.
Yu X and Xie J. 2012. Roles and underlying mechanisms of ESAT-6 in the context of
Mycobacterium tuberculosis–host interaction from a systems biology perspective.
Cellular Signalling. vol. 24. pp. 1841-1846.
Zhang W, Shu Q, Zhao Z, Fan J, Lyon CJ, Zelazny AM, Hu Y. 2018. Antigen 85B
peptidomic analysis allows species-specific mycobacterial identification. Clinical
Proteomics. vol. 15. pp. 1.
Zhang CY, Zhao F, Xia YY, Yu YL, Shen X, Lu W, Wang XM, Xing J, Ye JJ, Li JW,
Liu FY, Wu JL, Xu L, Zhang H, Cheng J, Wang LX. 2019. Prevalence and risk
factors of active pulmonary tuberculosis among elderly people in China: a
population based cross-sectional study. Infectious Diseases of Poverty. vol. 8.
no.1. pp. 7.
Zhao J, Shiratori B, Okumura M, Yanai H, Matsumoto M, Nakajima C, Mizuno K,
Ono K, Oda T, Chagan-Yasutan H, Ashino Y, Matsuba T, Yoshiyama T, Suzuki
Y, Hattori T. 2017a. Difference in antibody responses to mycobacterium
tuberculosis antigens in japanese tuberculosis patients infected with the
beijing/non-beijing genotype. Journal of Immunology Research. vol. 2017. pp.
4797856.
Zhao J, Matsuba T, Zhang X, Leano S, Nakajima C, Chagan-Yasutan H, Telan EF,
Suzuki Y, Hattori T. 2017b. Comparison of antibody responses against
Mycobacterium tuberculosis antigen Rv0679c in tuberculosis patients from the
endemic and non-endemic regions of the Beijing genotype: a case control study.
BMC Infectious Diseasess. vol. 14. pp. 344.
IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
DISERTASI PROFIL RESPONS IMUN ... DESAK NYOMAN SURYA SUAMEITRIA DEWI
Sampul DepanSampul DalamHalaman Prasyarat Gelar DoktorLembar PengesahanPenetapan Panitia PengujiUCAPAN TERIMA KASIHRINGKASANSUMMARYABSTRACTDAFTAR ISIDAFTAR TABELDAFTAR GAMBARDAFTAR LAMPIRANDAFTAR SINGKATANBAB 1 PENDAHULUANBAB 2 TINJAUAN PUSTAKABAB 3 KERANGKA KONSEP DAN HIPOTESIS PENELITIANBAB 4 METODE PENELITIANBAB 5 ANALISIS HASIL PENELITIANBAB 6 PEMBAHASANBAB 7 PENUTUPDAFTAR PUSTAKALAMPIRAN